[2]
Lamim, R., de Freitas, R. A., Rudek, E. I., Wilhelm, H. M., Cavalcanti, O. A. and Bresolin, T. M. B. (2006), Films of chitosan and N-carboxymethylchitosan, Part II: effect of plasticizers on their physiochemical properties, Polymer International, 55: 970–977.
DOI: 10.1002/pi.1959
Google Scholar
[3]
Jahren, S. L., Butler, M. F., Adams, S. and Cameron, R. E. (2010), Swelling and Viscoelastic Characterisation of pH-Responsive Chitosan Hydrogels for Targeted Drug Delivery, Macromolecular Chemistry and Physics, 211: 644–650.
DOI: 10.1002/macp.200900560
Google Scholar
[4]
Jessica D. Schiffman, Caroline L. Schauer, Cross-linking Chitosan Nanofibers, Biomacromolecules, 2007, 8 (2): 594–601.
DOI: 10.1021/bm060804s
Google Scholar
[5]
Gaserod O, Smidsrod O, Skjak-Braek G. Microcapsules of alginate-chitosan Ⅰ: A quantitative study of the interaction between alginate and chitosan[J], Biomaterials, 1998, 19(20): 1815-1825
DOI: 10.1016/s0142-9612(98)00073-8
Google Scholar
[6]
Maria Letizia Manca, Giuseppe Loy, Marco Zaru, Anna Maria Fadda, Sophia G. Antimisiaris, Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles, Colloids and Surfaces B: Biointerfaces, 2008, 67(2): 166-170
DOI: 10.1016/j.colsurfb.2008.08.010
Google Scholar
[7]
D.J. Ormrod, Sheryl Cawley, T.E. Miller, Extended immunosuppression with cyclophosphamide using controlled-release polymeric implants, International Journal of Immunopharmacology, 1985, 7(4): 443-448.
DOI: 10.1016/0192-0561(85)90062-1
Google Scholar
[8]
Hong Zhang, Megan Oh, Christine Allen, Eugenia Kumacheva. Monodisperse Chitosan Nanoparticles for Mucosal Drug Delivery. Biomacromolecules, 2004, 5(6): 2461–2468.
DOI: 10.1021/bm0496211
Google Scholar
[9]
A. Berthold, K. Cremer, J. Kreuter, Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs, Journal of Controlled Release, 1996, 39(1): 17-25.
DOI: 10.1016/0168-3659(95)00129-8
Google Scholar
[10]
Hassan EE. Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole, Pharmaceutical research, 1992-03-01; 9: 390-7.
Google Scholar
[11]
J. Akbua, G. Durmaz, Preparation and evaluation of cross-linked chitosan microspheres containing furosemide, International Journal of Pharmaceutics, 1994-10-27; 111(3):217-222.
DOI: 10.1016/0378-5173(94)90344-1
Google Scholar
[12]
Moshe Yair Levy, Abhinav Sidana, Wasim H. Chowdhury, Steven B. Solomon, Charles G. Drake, Ronald Rodriguez, and Ephraim J. Fuchs, Cyclophosphamide Unmasks an Antimetastatic Effect of Local Tumor Cryoablation, J Pharmacol Exp Ther, 2009; 330(2): 596–601.
DOI: 10.1124/jpet.109.152603
Google Scholar
[13]
Patashnik, S; Rabinovich, L; Golomb, G, Preparation and Evaluation of Chitosan Microspheres Containing Bisphosphonates, Journal of drug targeting, 1997, 4: 371-380
DOI: 10.3109/10611869709017894
Google Scholar
[14]
Anitha R. Dudhani, Shantha L. Kosaraju, Bioadhesive chitosan nanoparticles: Preparation and characterization, Carbohydrate Polymers, 2010-06-11; 81(2): 243-251.
DOI: 10.1016/j.carbpol.2010.02.026
Google Scholar
[15]
Chang, S. J., Niu, G. C.-C., Kuo, S. M. and Chen, S. F., Preparation and preliminary characterization of concentric multi-walled chitosan microspheres, J. Biomed. Mater. Res, 2007, 81A: 554–566.
DOI: 10.1002/jbm.a.31084
Google Scholar
[16]
Jun-gang Gao, Yue Zhang, Yi-feng Yu, Yu-cui Han, Bing-zhu Zhang and Chun-hui Gao, Preparation of chitosan microspheres loading of 3,5-dihydroxy-4-i-propylstilbene and in vitro release, Journal of Polymer Research, 2011, 18(6): 1501-1508.
DOI: 10.1007/s10965-010-9555-5
Google Scholar